Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology

Life Science

BeiGene Accepting Bids from Investors for $1 Billion Hong Kong IPO

Life Science

Consumer Healthcare Platform Igengmei Raises $50M Series D Round

Life Science

Merck Takes Lead from Bristol-Myers Squibb for PD-1/PD-L1

Life Science

Dynex Technologies Announces Global Partnership with ZEUS Scientific

Life Science

Aquestive Therapeutics Announces Closing of Initial Public Offering

Life Science

AstraZeneca’s key lung cancer drug wins European panel thumbs-up

Life Science

CBT Starts Phase Ib Trial of PD-1 Candidate in Australia

Life Science

HitGen Forms Another Drug Discovery Partnership — This One with Sanofi

Life Science

Wuxi AppTec to Proceed With Trials of Targeted Anti-Hepatoma Drug

Life Science

For US pot companies, Canada is the land of opportunity

Cannabis, Life Science

Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307

Life Science

I-Mab Out-Licenses Bi-Specific to South Korea’s ABL Bio in $100 Million Deal

Life Science

KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma

Life Science

Chinese Educator to Take 10% Stake in South Korea’s Chungdahm Learning

Life Science